2 results for "YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD."
Add this URL to any RSS reader. Updated daily.
Bioactive Phenolate Ionic Complexes, 21 Claims, US12606536B2
The USPTO granted Patent US12606536B2 to Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. for bioactive phenolate ionic complexes. The patent covers isolated materials comprising phenolate species and counter ions in the form of metal salts, phosphonium, or ammonium. Twenty-one claims were allowed.
Indoline Derivatives for Disease Treatment
The USPTO granted patent US12599584B2 to Yissum Research Development Company of The Hebrew University of Jerusalem Ltd. covering indoline derivatives and pharmaceutical compositions for treating diseases associated with oxidative stress, immune response, NO release, and pro-inflammatory cytokines. The patent names Marta Weinstock-Rosin, Abraham Nudelman, and Shani Zeeli as inventors and was filed on January 19, 2017. This grant establishes intellectual property protection for the therapeutic applications of these indoline compounds.
Get alerts for "YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD."
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Browse Categories
Get alerts for "YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD."
We'll email you when new changes match "YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD.".
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.